Not too much action today, Immucell drifted down slightly. We'll see where it goes next.
The Biotechnology company isn't at an immediate support or resistance level that might be predictive. Immucell has looked pretty good over the last few months. It has definitely cuaght a bid and had a nice run. Over the last 3 months, shareholders are no doubt pleased to see a 34.91 percent return. ICCC might find some support at the 6.36 level, buyers might push the price back up from here. But it's not very clear what will happen.
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 97 | 2.38753 | 3.62897 | 6.4432 | 17.3638 | 19.6152 | 41.5934 | 37.6907 | 13.404 | 12.9613 | 18.1372 | -15108.6 | -12240.5 | 2.8351 | 30.6701 | 6.86847 | 1.12814 |
| Healthcare | 226 | 1.69248 | 2.17252 | 8.5373 | 19.6677 | 18.2704 | 35.2118 | 42.4867 | 17.0885 | 11.4251 | 12.0497 | -12404.8 | -10962.7 | 4.2035 | 20.0221 | 5.36824 | 0.767434 |